Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
JDE Peet’s share buyback periodic update August 11, 2025
-
Mevolaxy Announces Record Payouts in June
-
Xtreme Asset Management Announces it is Expanding its Global Investment Reach in 2025 with Enhanced Institutional Partnerships
-
Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial
-
Net Asset Value(s)
-
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
-
Rail Vision Receives European Patent for Innovative Locomotive Imaging Technology
-
Correction: AS Tallinna Sadam financial results for 2025 Q2 and 6 months
-
Nexxen Renews and Expands its Strategic Partnership with VIDAA, with a Focus on Growing VIDAA’s North American CTV Footprint
-
L.B. Foster Announces Strong Second Quarter Results with Organic Growth and Profitability Expansion Expected to Continue Through Balance of 2025
-
Winshear Enters Option Agreement on the Portsoy Nickel – Copper – Cobalt Project, Scotland
-
Matador Acquires 5 Bitcoin for CAD$802,020, Bringing Its Total Bitcoin (and Bitcoin Equivalent) Holdings to 77.4
-
MAX Power Partners with Caram Media and TMI Digital to Drive Strategic Marketing and Spotlight Natural Hydrogen Story
-
Altimmune Board of Directors Appoints Jerry Durso as Chairman
-
Fox River Announces Funding Award from the Critical Minerals Innovation Fund
-
Avicanna Announces US Patent and Trademark Office Issuance of New Patent
-
Nayax Announces Strategic Partnership with Leading Global EVSE Provider Autel Energy to Deliver Embedded Payment Solutions
-
Magna to Showcase Its Vision for Safer, Smarter, Greener Mobility at IAA Mobility 2025
-
Exodus and MetaMask Partner to Bring XO Swap’s Bridge Functionality to Millions of Wallet Users
-
MiniLuxe Announces Planned Share Issuance for a New Studio Location Acquisition in the DFW (Dallas Fort Worth) Region
-
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025
-
Lithium Argentina Reports Second Quarter 2025 Results
-
Kinross Files Early Warning Report with respect to Asante Gold
-
Kraig Biocraft Laboratories to Launch Operations at New Southeast Asia Production Facility This Week
-
Plum Role Model™ Named a 2025 Top HR Product of the Year by HR Executive
-
American Tungsten Provides Update on Site Rehabilitation Progress and Federal Engagement
-
Papa Johns Canada Brings Hawaii Home with The Aloha Trio
-
Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030
-
NBB, a leading Automotive M&A Advisory firm, Names Experienced Investment Banker Zach Kuzemka as new Chief Executive Officer
-
BioCryst Announces Departure of Dr. Helen Thackray
-
Kamada Announces FDA Approval of its Plasma Collection Center in Houston, Texas
-
Rocky Shore Gold Announces Non-Brokered Private Placement
-
NBB, a leading Automotive M&A Advisory firm, Names Experienced Investment Banker Zach Kuzemka as new Chief Executive Officer
-
WeightWatchers Announces Second Quarter 2025 Results
-
Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results
-
Asante Signs Definitive Agreements to Unlock Approximately $500M of Financing Proceeds
-
Humacyte Announces Second Quarter 2025 Financial Results and Provides Business Update
-
FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response
-
Compass Therapeutics Reports 2025 Second Quarter Financial Results and Provides Corporate Update
-
I-Mab Completes Enrollment in Planned Phase 1b Dose Expansion Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers
-
Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update
-
And the Winners Are: HR Executive and HR Tech Announce 2025 Top HR Products of the Year
-
FDA Clears IND for SEED Therapeutics’ RBM39 Degrader ST-01156
-
BioXcel Therapeutics to Participate in Canaccord Genuity 45th Annual Growth Conference
-
Sionna Therapeutics Reports Second Quarter 2025 Financial Results
-
FitLife Brands Closes Acquisition of Irwin Naturals
-
Village Farms International Delivers Record Profitability and Performance from Continuing Operations in Q2/25
-
Intermex Reports Second-Quarter Results
-
Harvard Bioscience Announces Second Quarter 2025 Financial Results
-
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2025

